Chemical Biology Approach for Validating and Manipulating Cellular RNA-Protein Interactions

验证和操纵细胞 RNA-蛋白质相互作用的化学生物学方法

基本信息

  • 批准号:
    10021031
  • 负责人:
  • 金额:
    $ 30.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-20 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Recent studies have shown that RNAs are invariably bound to and often modified by RNA-binding proteins (RBPs). Thus, it is no surprise that RBPs have been found to play key roles in regulating many aspects of coding and non-coding RNA biology, including RNA processing, nuclear export, cellular transport, function, localization, and stability. These efforts are carried out by >1,500 unique RBPs that utilize a variety of RNA- binding domains to achieve oftentimes specific and high affinity interactions with target transcripts; however, non-canonical RBPs have also been identified. Disruption of this complex network of RNA-protein interactions (RPIs) has been implicated in a number of human diseases. Thus, the targeting of RBPs and RPIs has arisen as a new frontier in RNA-targeted drug discovery; however, very few interactions have been validated to support a pipeline of targets for these efforts. While the advent of sequencing and quantitative mass spectrometry has dramatically enhanced our ability to globally profile these interactions, experimental validation of these data sets remains a challenge. Using chemical biology- and bioorthogonal chemistry-based strategies, we have developed an innovative new assay for the live-cell detection of RPIs, RNA interaction with Protein-mediated Complementation Assay, or RiPCA. Through this approach, we have detected the interaction of pre-miRNAs with RBPs, in addition to inhibition with small molecules. Moreover, to provide evidence for the potential of our technology in validating new RPIs, we used RiPCA to confirm the interaction of a pre-miRNA with a novel RBP discovered via proteomics. In total, these data provide encouraging proof-of- concept for this emerging technology; yet, many key questions and challenges still remain to ensure that RiPCA is a rigorous and unbiased approach for the detection of RPIs in distinct cellular organelles. In Specific Aim 1, we will further develop RiPCA for organelle-specific detection to ensure its accuracy. In Specific Aim 2, we will investigate the potential of the assay by profiling additional RPIs from various RNA and RBP families. Finally, in Specific Aim 3, we will explore its adaptability toward high-throughput experimentation for validation of large-scale CLIP or proteomics data sets, or screening to identify cell-active small molecule inhibitors of RPIs. Upon completion of the proposed research, our goal is to produce a robust and user-friendly technology for the rapid validation and study of cellular RPIs to enable biomedical research.
最近的研究表明,rna总是与rna结合蛋白结合并经常被rna结合蛋白修饰

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amanda Garner其他文献

Amanda Garner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amanda Garner', 18)}}的其他基金

Delineating the Biology of Translational Repressor 4E-BP1
描述翻译抑制子 4E-BP1 的生物学
  • 批准号:
    10457381
  • 财政年份:
    2020
  • 资助金额:
    $ 30.81万
  • 项目类别:
Delineating the Biology of Translational Repressor 4E-BP1
描述翻译抑制子 4E-BP1 的生物学
  • 批准号:
    10244869
  • 财政年份:
    2020
  • 资助金额:
    $ 30.81万
  • 项目类别:
Delineating the Biology of Translational Repressor 4E-BP1
描述翻译抑制子 4E-BP1 的生物学
  • 批准号:
    10725026
  • 财政年份:
    2020
  • 资助金额:
    $ 30.81万
  • 项目类别:
Delineating the Biology of Translational Repressor 4E-BP1
描述翻译抑制子 4E-BP1 的生物学
  • 批准号:
    10674061
  • 财政年份:
    2020
  • 资助金额:
    $ 30.81万
  • 项目类别:
Delineating the Biology of Translational Repressor 4E-BP1
描述翻译抑制子 4E-BP1 的生物学
  • 批准号:
    10629541
  • 财政年份:
    2020
  • 资助金额:
    $ 30.81万
  • 项目类别:
Chemical Biology Approach for Validating and Manipulating Cellular RNA-Protein Interactions
验证和操纵细胞 RNA-蛋白质相互作用的化学生物学方法
  • 批准号:
    10468874
  • 财政年份:
    2019
  • 资助金额:
    $ 30.81万
  • 项目类别:
Chemical Biology Approach for Validating and Manipulating Cellular RNA-Protein Interactions
验证和操纵细胞 RNA-蛋白质相互作用的化学生物学方法
  • 批准号:
    10242059
  • 财政年份:
    2019
  • 资助金额:
    $ 30.81万
  • 项目类别:
Chemical Biology Approach for Validating and Manipulating Cellular RNA-Protein Interactions
验证和操纵细胞 RNA-蛋白质相互作用的化学生物学方法
  • 批准号:
    10408902
  • 财政年份:
    2019
  • 资助金额:
    $ 30.81万
  • 项目类别:
Chemical Biology Approach for Validating and Manipulating Cellular RNA-Protein Interactions
验证和操纵细胞 RNA-蛋白质相互作用的化学生物学方法
  • 批准号:
    10700424
  • 财政年份:
    2019
  • 资助金额:
    $ 30.81万
  • 项目类别:
Discovery of Selective Small Molecule Probes for pre-microRNAs
发现前 microRNA 的选择性小分子探针
  • 批准号:
    9242657
  • 财政年份:
    2016
  • 资助金额:
    $ 30.81万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 30.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 30.81万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 30.81万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 30.81万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 30.81万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 30.81万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 30.81万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 30.81万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 30.81万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 30.81万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了